litlas
Log inCreate account

Johan Hansson

Active 1987–2022

96
Papers
19,497
Citations
78
h-index
95
i10-index

Citations

Citations per year for Johan Hansson1976: 1 citations1988: 3 citations1989: 3 citations1990: 6 citations1991: 19 citations1992: 16 citations1993: 14 citations1994: 12 citations1995: 8 citations1996: 17 citations1997: 22 citations1998: 25 citations1999: 34 citations2000: 29 citations2001: 27 citations2002: 32 citations2003: 55 citations2004: 66 citations2005: 78 citations2006: 64 citations2007: 80 citations2008: 78 citations2009: 147 citations2010: 191 citations2011: 216 citations2012: 188 citations2013: 251 citations2014: 238 citations2015: 270 citations2016: 288 citations2017: 280 citations2018: 234 citations2019: 646 citations2020: 744 citations2021: 659 citations2022: 463 citations2023: 324 citations2024: 505 citations2025: 173 citations2026: 12 citations1977–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,488 citing papers, 24.8% of this breakdownChina: 709 citing papers, 7.1% of this breakdownUnited Kingdom: 681 citing papers, 6.8% of this breakdownGermany: 623 citing papers, 6.2% of this breakdownItaly: 572 citing papers, 5.7% of this breakdownAustralia: 493 citing papers, 4.9% of this breakdownFrance: 445 citing papers, 4.4% of this breakdownNetherlands: 429 citing papers, 4.3% of this breakdownSweden: 346 citing papers, 3.4% of this breakdownSpain: 305 citing papers, 3% of this breakdownCanada: 270 citing papers, 2.7% of this breakdownSwitzerland: 232 citing papers, 2.3% of this breakdown
0%24.8%Other 24.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology42.2%
  • Medicine40.6%
  • Immunology and Microbiology10%
  • Health Professions1.8%
  • Engineering1.5%
  • Neuroscience0.9%
  • Other3%

Topics

  • Melanoma and MAPK Pathways8.1%
  • Cutaneous Melanoma Detection and Management6.3%
  • Cancer Immunotherapy and Biomarkers5.7%
  • Immunotherapy and Immune Responses4%
  • CAR-T cell therapy research2.9%
  • Immune cells in cancer2.6%
  • Other70.4%

Coauthors

All papers

Open in search
  1. Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

    Authors: Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas, E. Levchenko, Filippo de Braud, James Larkin, Claus Garbe, Thomas Jouary, Axel Hauschild, Jean‐Jacques Grob, Vanna Chiarion‐Sileni, Célèste Lebbé, Mario Mandalà, Michael Millward, Ana Arance, Igor Bondarenko, John B.A.G. Haanen, Johan Hansson, Jochen Utikal, Virginia Ferraresi, Н. В. Коваленко, Peter Mohr, Volodymyr Probachai, Dirk Schadendorf, Paul Nathan, Caroline Robert, Antoni Ribas, Douglas J. DeMarini, Jhangir G Irani, Michelle Casey, Danièle Ouellet, Anne‐Marie Martin, Ngocdiep T. Le, Kiran Patel, Keith T. Flaherty - New England Journal of Medicine 2014 cited by 1,871

  2. Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma

    Authors: Kim Thrane, Hanna Eriksson, Jonas Maaskola, Johan Hansson, Joakim Lundeberg - Cancer Research 2018 cited by 368

  3. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

    Authors: Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi, Chandra Mani Adhikari, Carolien Bierman, Bart A. van de Wiel, Richard A. Scolyer, Oscar Krijgsman, Karolina Sikorska, Hanna Eriksson, Annegien Broeks, Johannes V. van Thienen, Alexander Guminski, Alex Torres Acosta, Sylvia ter Meulen, Anne Miek Koenen, Linda J.W. Bosch, Kerwin F. Shannon, Loes M. Pronk, Maria Gonzalez, Sydney Ch’ng, Lindsay G. Grijpink-Ongering, Jonathan R. Stretch, Stijn W. T. P. J. Heijmink, Harm van Tinteren, John B.A.G. Haanen, Omgo E. Nieweg, W. Martin C. Klop, Charlotte L. Zuur, Robyn P.M. Saw, Winan J. van Houdt, Daniel S. Peeper, Andrew J. Spillane, Johan Hansson, Ton N. Schumacher, Georgina V. Long, Christian U. Blank - The Lancet Oncology 2019 cited by 522

  4. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

    Authors: Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas, E. Levchenko, Filippo de Braud, James Larkin, Claus Garbe, Thomas Jouary, Axel Hauschild, Jean‐Jacques Grob, Vanna Chiarion‐Sileni, Célèste Lebbé, Mario Mandalà, Michael Millward, Ana Arance, Igor Bondarenko, John B.A.G. Haanen, Johan Hansson, Jochen Utikal, Virginia Ferraresi, Н. В. Коваленко, Peter Mohr, Volodymr Probachai, Dirk Schadendorf, Paul Nathan, Caroline Robert, Antoni Ribas, Douglas J. DeMarini, Jhangir G Irani, S. Swann, Jeffrey J. Legos, Fan Jin, Bijoyesh Mookerjee, Keith T. Flaherty - The Lancet 2015 cited by 1,386

  5. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

    Authors: Maria Teresa Landi, D. Timothy Bishop, Stuart MacGregor, Mitchell J. Machiela, Alexander Stratigos, Paola Ghiorzo, Myriam Brossard, Donato Calista, Jiyeon Choi, Maria Concetta Fargnoli, Tongwu Zhang, Monica Rodolfo, Adam J. Trower, Chiara Menin, J. Julian Martinez, Andreas Hadjisavvas, Lei Song, Irene Stefanaki, Richard A. Scolyer, Rose Yang, Alisa M. Goldstein, Míriam Potrony, Katerina Kypreou, Lorenza Pastorino, Paola Queirolo, Cristina Pellegrini, Laura Cattaneo, Matthew Zawistowski, Pol Giménez‐Xavier, A. L. Rodriguez, Lisa Elefanti, Siranoush Manoukian, Licia Rivoltini, Blair H. Smith, Maria A. Loizidou, Laura Del Regno, Daniela Massi, Mario Mandalà, Kiarash Khosrotehrani, Lars A. Akslen, Christopher I. Amos, Per Arne Andresen, Marie‐Françoise Avril, Esther Azizi, H. Peter Soyer, Véronique Bataille, Bruna Dalmasso, Lisa Bowdler, Kathryn P. Burdon, Wei V. Chen, Veryan Codd, Jamie E. Craig, Tadeusz Dębniak, Mario Falchi, Shenying Fang, Eitan Friedman, Sarah Simi, Pilar Galán, Zaida García‐Casado, Elizabeth M. Gillanders, Scott D. Gordon, Adèle C. Green, Nelleke A. Gruis, Johan Hansson, Mark Harland, Jessica Harris, Per Helsing, Anjali K. Henders, Marko Hočevar, Veronica Höiom, David J. Hunter, Christian Ingvar, Rajiv Kumar, Julie Lang, G.M. Lathrop, Jeffrey E. Lee, Xin Li, Jan Lubiński, Rona M. MacKie, M. Malt, Josep Malvehy, Kerrie McAloney, Hamida Mohamdi, Anders Molven, Eric K. Moses, Rachel Ε. Neale, Srdjan Novaković, Dale R. Nyholt, Håkan Olsson, Nick Orr, Lars G. Fritsche, Joan Anton Puig‐Butille, Abrar A. Qureshi, Graham Radford‐Smith, Juliette A. Randerson‐Moor, Celia Requena, Casey Rowe, Nilesh J. Samani, Marianna Sanna, Dirk Schadendorf and 59 more - Nature Genetics 2020 cited by 239

  6. Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

    Authors: Nicole Basset‐Séguin, Axel Hauschild, Rainer Kunstfeld, Jean‐Jacques Grob, Brigitte Dréno, Laurent Mortier, Paolo A. Ascierto, Lisa Licitra, Caroline Dutriaux, L. Thomas, Nicolás Meyer, B. Guillot, Reinhard Dummer, Petr Arenberger, Kate Fife, A. Raimundo, Emi Dika, Natalie Dimier, A. Fittipaldo, Ioannis Xynos, Johan Hansson - European Journal of Cancer 2017 cited by 284

  7. Skin cancer identification using multifrequency electrical impedance-a potential screening tool

    Authors: Peter Aberg, Ingrid Nicander, Johan Hansson, Paul Geladi, Ulf Holmgren, Stig Ollmar - IEEE Transactions on Biomedical Engineering, IEEE Trans. Biomed. Eng. 2004 cited by 300

  8. Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

    Authors: Yago Pico de Coaña, Maria Wolodarski, Isabel Poschke, Yuya Yoshimoto, Yuan Yang, Maria Nyström, Ulrika Edbäck, Suzanne Eghyazi Brage, Andreas Lundqvist, Giuseppe Masucci, Johan Hansson, Rolf Kiessling - Oncotarget 2017 cited by 142

  9. A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

    Authors: Omid Hamid, Henrik Schmidt, Aviram Nissan, Laura Ridolfi, Steinar Aamdal, Johan Hansson, Michele Guida, David M. Hyams, Henry Gómez, Lars Bastholt, Scott D. Chasalow, David M. Berman - Journal of Translational Medicine 2011 cited by 531

  10. Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma

    Authors: Soudabeh Rad Pour, Hiromasa Morikawa, Narsis A. Kiani, Muyi Yang, Alireza Azimi, Gowhar Shafi, Ming-Mei Shang, Roland Baumgartner, Daniel F.J. Ketelhuth, Muhammad Anas Kamleh, Craig E. Wheelock, Andreas Lundqvist, Johan Hansson, Jesper Tegnér - Scientific Reports 2019 cited by 81

  11. Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic Signaling

    Authors: Aleksandra Mandic, Johan Hansson, Stig Linder, Maria C. Shoshan - Journal of Biological Chemistry 2003 cited by 500

  12. Suffering in silence: a qualitative study of second victims of adverse events

    Authors: Susanne Ullström, Magna Andreen Sachs, Johan Hansson, John Øvretveit, Mats Brommels - BMJ Quality & Safety 2013 cited by 337

  13. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

    Authors: Alisa M Goldstein, May Chan, Mark Harland, Nicholas K. Hayward, Florence Démenais, D. Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi‐Scarrà, William Bruno, Donato Calista, Lisa Cannon‐Albright, Valérie Chaudru, Agnès Chompret, Francisco Cuellar, David E Elder, Paola Ghiorzo, Elizabeth M. Gillanders, Nelleke A. Gruis, Johan Hansson, David Hogg, Elizabeth A Holland, Peter A. Kanetsky, Richard Kefford, M.T. Landi, Julie Lang, Sancy A. Leachman, R.M. MacKie, Veronica Magnusson, Graham J. Mann, Julia Newton‐Bishop, Jane M. Palmer, Susana Puig, Joan A. Puig‐Butille, Mitchell Stark, Hensin Tsao, M. A. Tucker, Linda Whitaker, Emanuel Yakobson - Journal of Medical Genetics 2006 cited by 475

  14. Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

    Authors: Yumeng Mao, Isabel Poschke, Erik Wennerberg, Yago Pico de Coaña, Suzanne Egyházi Brage, Inkeri Schultz, Johan Hansson, Giuseppe Masucci, Andreas Lundqvist, Rolf Kiessling - Cancer Research 2013 cited by 186

  15. Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

    Authors: Tanja Lövgren, Maria Wolodarski, Stina L. Wickström, Ulrika Edbäck, Mette Wallin, Eva Martell, Katrin Markland, Pontus Blomberg, Maria Nyström, Andreas Lundqvist, Hans Jacobsson, Gustav Ullenhag, Per Ljungman, Johan Hansson, Giuseppe Masucci, Roger Tell, Isabel Poschke, Lars Adamson, Jonas Mattsson, Rolf Kiessling - OncoImmunology 2020 cited by 50

  16. Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicity

    Authors: Koji Kono, Flavio Salazar‐Onfray, Max Petersson, Johan Hansson, Giuseppe Masucci, Ken Wasserman, Tsutomu Nakazawa, Paul Anderson, Rolf Kiessling - European Journal of Immunology 1996 cited by 361

  17. Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

    Authors: Yago Pico de Coaña, Isabel Poschke, Giusy Gentilcore, Yumeng Mao, Maria Nyström, Johan Hansson, Giuseppe Masucci, Rolf Kiessling - Cancer Immunology Research 2013 cited by 138

  18. FBXW7/hCDC4 Is a General Tumor Suppressor in Human Cancer

    Authors: Shahab Akhoondi, Dahui Sun, Natalie von der Lehr, Sophia Apostolidou, Kathleen Klotz, Alena Maljukova, Diana Cepeda, Heidi Fiegl, Dimitra Dofou, Christian Marth, Elisabeth Mueller‐Holzner, Martin Corcoran, Markus Dagnell, Sepideh Zabihi Nejad, Babak Noori Nayer, Mohammad Reza Zali, Johan Hansson, Susanne Egyhazi, Fredrik Petersson, Per Sangfelt, Hans Nordgren, Dan Grandér, Steven I. Reed, Martin Widschwendter, Olle Sangfelt, Charles Spruck - Cancer Research 2007 cited by 519

  19. High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

    Authors: Alisa M. Goldstein, May Chan, Mark Harland, Elizabeth M. Gillanders, Nicholas K. Hayward, Marie-Françoise Avril, Esther Azizi, Giovanna Bianchi‐Scarrà, D. Timothy Bishop, Brigitte Bressac–de Paillerets, William Bruno, Donato Calista, Lisa Cannon‐Albright, Florence Démenais, David E. Elder, Paola Ghiorzo, Nelleke A. Gruis, Johan Hansson, David Hogg, Elizabeth A. Holland, Peter A. Kanetsky, Richard Kefford, Maria Teresa Landi, Julie Lang, Sancy A. Leachman, Rona M. MacKie, Veronica Magnusson, Graham J. Mann, Kristin B. Niendorf, Julia Newton‐Bishop, Jane M. Palmer, Susana Puig, Joan A. Puig‐Butille, Femke A. de Snoo, Mitchell Stark, Hensin Tsao, Margaret A. Tucker, Linda Whitaker, Emanuel Yakobson, The Lund Melanoma Study Group - Cancer Research 2006 cited by 418

  20. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma

    Authors: Daníel F. Guðbjartsson, Patrick Sulem, Simon Stacey, Alisa M. Goldstein, Þórunn Rafnar, Bárður Sigurgeirsson, Kristrún R. Benediktsdóttir, Kristin Thorisdottir, Rafn Ragnarsson, Steinunn G Sveinsdottir, Veronica Magnusson, Annika Lindblom, Konstantinos Kostulas, Rafael Botella‐Estrada, Vincent Soriano, Pablo Juberías, Matilde Grasa, Berta Sáez, R. Andrés, Dominique Scherer, Péter Rudnai, Eugen Gurzău, Kvetoslava Koppová, Lambertus A. Kiemeney, Margret Jakobsdottir, Stacy Steinberg, Agnar Helgason, Sólveig Grétarsdóttir, Margaret A. Tucker, José Mayordomo, Eduardo Nagore, Rajiv Kumar, Johan Hansson, Jón Ólafsson, Jeffrey R. Gulcher, Augustine Kong, Unnur Þorsteinsdóttir, Kāri Stefánsson - Nature Genetics 2008 cited by 355

  21. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases

    Authors: Abdlsattar Zebary, Mattias Jangard, Katarina Omholt, Boel Ragnarsson-Olding, Johan Hansson - British Journal of Cancer 2013 cited by 171

  22. Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign

    Authors: Isabel Poschke, Dimitrios Mougiakakos, Johan Hansson, Giuseppe Masucci, Rolf Kiessling - Cancer Research 2010 cited by 377

  23. Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas

    Authors: Keiran S.M. Smalley, Mercedes Lioni, Maurizia Dalla Palma, Min Xiao, Brijal Desai, Suzanne Egyházi, Johan Hansson, Hong Wu, Alastair J. King, Patricia Van Belle, David E. Elder, Keith T. Flaherty, Meenhard Herlyn, Katherine L. Nathanson - Molecular Cancer Therapeutics 2008 cited by 293

  24. Genome-wide association study identifies three loci associated with melanoma risk

    Authors: D. Timothy Bishop, Florence Démenais, Mark M. Iles, Mark Harland, John Taylor, Eve Corda, Juliette A. Randerson‐Moor, Joanne F. Aitken, Marie‐Françoise Avril, Esther Azizi, Egbert Bakker, Giovanna Bianchi‐Scarrà, Brigitte Bressac–de Paillerets, Donato Calista, Lisa Cannon‐Albright, Thomas F. C. Chin‐A‐Woeng, Tadeusz Dębniak, Gilli Galore-Haskel, Paola Ghiorzo, Marta Gut, Johan Hansson, Marko Hočevar, Veronica Höiom, John L. Hopper, Christian Ingvar, Peter A. Kanetsky, Richard Kefford, Maria Teresa Landi, Julie Lang, Jan Lubiński, Rona M. MacKie, Josep Malvehy, Graham J. Mann, Nicholas G. Martin, Grant W. Montgomery, Frans A. van Nieuwpoort, Srdjan Novaković, Håkan Olsson, Susana Puig, Marjan M. Weiss, Wilbert van Workum, Diana Zélénika, Kevin M Brown, Alisa M. Goldstein, Elizabeth M. Gillanders, Anne Boland, Pilar Galán, David E. Elder, Nelleke A. Gruis, Nicholas K. Hayward, G.M. Lathrop, Jennifer H. Barrett, Julia Newton‐Bishop - Nature Genetics 2009 cited by 464